Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An autosomal recessive metabolic disorder characterized by delayed psychomotor development and lactic acidosis with a normal lactate/pyruvate ratio resulting from impaired mitochondrial pyruvate oxidation.
Features include sometimes findings: Epicanthus, Encephalopathy, Progressive microcephaly, and Rotary nystagmus and others. 18 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 4 | Encephalopathy, Seizure, Global developmental delay |
MPC1 encodes mitochondrial pyruvate carrier 1 (109 aa). Mediates the uptake of pyruvate into mitochondria to maintain the balance between glycolysis and oxidative phosphorylation. Plays an essential role in cellular metabolism Highest expression in Heart Left Ventricle (168.8 TPM) and Brain Spinal cord cervical c-1 (164.5 TPM).
Mitochondrial pyruvate carrier deficiency is associated with mutations in the MPC1 gene on chromosome 6.
The MPC1 protein participates in MPC1:MPC2 imports PYR, H+ to mitochondrial matrix pathway.
MPC1 is classified as a druggable target (Transporter category) with score 0.0.
Genetic testing for MPC1 is available. Testing is considered confirmatory for diagnosis.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for mitochondrial pyruvate carrier deficiency.
3 publications have been identified in PubMed for mitochondrial pyruvate carrier deficiency. Research spans Basic Science / Preclinical (100%).
Zhu Q (2026). [PMID: 41576477](https://pubmed.ncbi.nlm.nih.gov/41576477/). *Biochem Biophys Res Commun*. [Basic Science / Preclinical]
Fu Y (2026). [PMID: 42137567](https://pubmed.ncbi.nlm.nih.gov/42137567/). *Front Pediatr*. [Basic Science / Preclinical]
Barile SN (2025). [PMID: 41398145](https://pubmed.ncbi.nlm.nih.gov/41398145/). *Cell Death Dis*. [Basic Science / Preclinical]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 6:55 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
2 |
Progressive microcephaly, Thin upper lip vermilion |
Lab test results | 2 | Increased circulating pyruvate concentration, Increased circulating lactate concentration |
Muscles | 2 | Low muscle tone (hypotonia), Generalized hypotonia |
Eyes | 1 | Rotary nystagmus |
Lungs and breathing | 1 | Respiratory distress |
Digestive system | 1 | Enlarged liver (hepatomegaly) |